Lista de obras -

Analysis of SjTREC levels in thymus from MG patients and normal children.

artículo científico publicado en 2003

Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association

artículo científico publicado en 2004

Concordance between severity of disease, disability and health-related quality of life in Myasthenia gravis

article

Disability and functional profiles of patients with myasthenia gravis measured with ICF classification

artículo científico publicado en 2009

Expression of transforming growth factor-beta1 in thymus of myasthenia gravis patients: correlation with pathological abnormalities.

artículo científico publicado en 2003

Fibrogenic cytokines and extent of fibrosis in muscle of dogs with X-linked golden retriever muscular dystrophy

artículo científico publicado en 2002

Identification of international classification of functioning, disability and health relevant categories to describe functioning and disability of patients with myasthenia gravis

artículo científico publicado en 2009

Identification of previously unreported mutations in CHRNA1, CHRNE and RAPSN genes in three unrelated Italian patients with congenital myasthenic syndromes

artículo científico publicado en 2010

Immunization with rat-, but not Torpedo-derived 97-116 peptide of the AChR alpha-subunit induces experimental myasthenia gravis in Lewis rat

scientific article published on 01 September 2003

Immunomodulation of TGF-beta1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: Implications for antifibrotic therapy

artículo científico publicado en 2006

Increased toll-like receptor 4 expression in thymus of myasthenic patients with thymitis and thymic involution.

artículo científico publicado en 2005

Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study

artículo científico publicado en 2003

Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy

artículo científico publicado en 2012

Myasthenia gravis (MG): epidemiological data and prognostic factors

artículo científico publicado en 2003

Narcolepsy is a common phenotype in HSAN IE and ADCA-DN.

artículo científico publicado en 2014

Opposing roles of miR-21 and miR-29 in the progression of fibrosis in Duchenne muscular dystrophy.

artículo científico publicado en 2015

Polysomnographic and neurometabolic features may mark preclinical autosomal dominant cerebellar ataxia, deafness, and narcolepsy due to a mutation in the DNA (cytosine-5-)-methyltransferase gene, DNMT1.

artículo científico publicado en 2014

Risk factors for tumor occurrence in patients with myasthenia gravis

artículo científico publicado en 2009

The relationship between health, disability and quality of life in myasthenia gravis: results from an Italian study

artículo científico publicado en 2009

Thymoma-associated myasthenia gravis: Outcome, clinical and pathological correlations in 197 patients on a 20-year experience

artículo científico publicado en 2008

Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy (T-3b) in non-thymomatous myasthenia gravis patients: remission after 6 years of follow-up

artículo científico publicado en 2003

Lista de obras de

Analysis of SjTREC levels in thymus from MG patients and normal children.

Anti-MOG autoantibodies in Italian multiple sclerosis patients: specificity, sensitivity and clinical association

Concordance between severity of disease, disability and health-related quality of life in Myasthenia gravis

Disability and functional profiles of patients with myasthenia gravis measured with ICF classification

Expression of transforming growth factor-beta1 in thymus of myasthenia gravis patients: correlation with pathological abnormalities.

Fibrogenic cytokines and extent of fibrosis in muscle of dogs with X-linked golden retriever muscular dystrophy

Identification of international classification of functioning, disability and health relevant categories to describe functioning and disability of patients with myasthenia gravis

Identification of previously unreported mutations in CHRNA1, CHRNE and RAPSN genes in three unrelated Italian patients with congenital myasthenic syndromes

Immunization with rat-, but not Torpedo-derived 97-116 peptide of the AChR alpha-subunit induces experimental myasthenia gravis in Lewis rat

Immunomodulation of TGF-beta1 in mdx mouse inhibits connective tissue proliferation in diaphragm but increases inflammatory response: Implications for antifibrotic therapy

Increased toll-like receptor 4 expression in thymus of myasthenic patients with thymitis and thymic involution.

Muscle inflammation and MHC class I up-regulation in muscular dystrophy with lack of dysferlin: an immunopathological study

Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy

Myasthenia gravis (MG): epidemiological data and prognostic factors

Narcolepsy is a common phenotype in HSAN IE and ADCA-DN.

Opposing roles of miR-21 and miR-29 in the progression of fibrosis in Duchenne muscular dystrophy.

Polysomnographic and neurometabolic features may mark preclinical autosomal dominant cerebellar ataxia, deafness, and narcolepsy due to a mutation in the DNA (cytosine-5-)-methyltransferase gene, DNMT1.

Risk factors for tumor occurrence in patients with myasthenia gravis

The relationship between health, disability and quality of life in myasthenia gravis: results from an Italian study

Thymoma-associated myasthenia gravis: Outcome, clinical and pathological correlations in 197 patients on a 20-year experience

Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy (T-3b) in non-thymomatous myasthenia gravis patients: remission after 6 years of follow-up